首页>European journal of clinical pharmacology>No differences in the pharmacodynamics and pharmacokinetics of the thrombin receptor antagonist vorapaxar between healthy Japanese and Caucasian subjects
No differences in the pharmacodynamics and pharmacokinetics of the thrombin receptor antagonist vorapaxar between healthy Japanese and Caucasian subjects
作者单位：Merck Sharp and Dohme Corp., Whitehouse Station, NJ, United States, Clinical Pharmacology, Merck[1]Merck Sharp and Dohme Corp., Whitehouse Station, NJ, United States[2]University of Tennessee, Health Science Center, Memphis, TN, United States[3]
换一批
